Nociceptin/orphanin FQ. A new opioid, a new analgesic?
Opioids form the major class of strong analgesics. Endogenous opioids and their receptors play important roles in central nervous system function. Thus, the discovery of a new opioid peptide, nociceptin or orphanin FQ, and its receptor, opioid receptor-like 1 (ORL-1) has caused considerable interest since this transmitter system appears to exhibit a number of key differences to the other opioids. Analgesia can be produced at spinal sites but there is compelling evidence that the peptide may also have 'anti-opioid' actions in the brain. Effects on auditory processing, pains from nerve injury coupled with an apparent lack of motivational effects have important implications for novel therapy. This review surveys the recent functional studies on this novel peptide.
Department of Pharmacology, University College, London, UK.
F
F
Taylor
A
A
Dickenson
D000595:Amino Acid Sequence; D000701:Analgesics, Opioid / Q000494:pharmacology*; D000818:Animals; D006801:Humans; D008969:Molecular Sequence Data; D018847:Opioid Peptides / Q000494:pharmacology*; D011957:Receptors, Opioid / Q000819:agonists*; D000097629:Nociceptin
D000701:Analgesics, Opioid; D018847:Opioid Peptides; D011957:Receptors, Opioid; D000097629:Nociceptin